Lead BDC Candidate(s)

About Stradefy Biosciences

Stradefy Biosciences is a private, preclinical-stage biotech developing a novel drug delivery platform called Bioadhesive Drug Carriers (BDCs). The technology aims to surpass the efficacy of ADCs by enabling higher drug loads and optimized retention and internalization in target cells. With lead candidates demonstrating in vivo proof of efficacy in oncology models, the company is advancing toward IND-enabling studies with a capital-efficient strategy. It is based on foundational research from Yale University and is backed by Elm Street Ventures.

Therapeutic Areas

Other Oncology (unspecified) Drugs